An Italian Multicenter Perspective Harmonization Trial for the Assessment of MET Exon 14 Skipping Mutations in Standard Reference Samples
Lung cancer remains the leading cause of cancer deaths worldwide. International societies have promoted the molecular analysis of MET proto-oncogene, receptor tyrosine kinase (<i>MET</i>) exon 14 skipping for the clinical stratification of non-small cell lung cancer (NSCLC) patients. Dif...
Main Authors: | Paolo Bironzo, Francesco Pepe, Gianluca Russo, Pasquale Pisapia, Gianluca Gragnano, Gabriella Aquino, Silvia Bessi, Simonetta Buglioni, Federico Bartoccini, Giuseppina Ferrero, Michela Anna Bresciani, Paola Francia di Celle, Francesca Sibona, Andrea Giusti, Alessandra Movilia, Renata Mariella Farioli, Alessandra Santoro, Domenico Salemi, Stefania Scarpino, Dino Galafate, Stefania Tommasi, Rosanna Lacalamita, Davide Seminati, Elham Sajjadi, Silvia Novello, Fabio Pagni, Giancarlo Troncone, Umberto Malapelle |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/13/4/629 |
Similar Items
-
Economic assessment of NGS testing workflow for NSCLC in a healthcare setting
by: Davide Seminati, et al.
Published: (2024-04-01) -
BRAF: A Two-Faced Janus
by: Pasquale Pisapia, et al.
Published: (2020-11-01) -
Liquid Biopsy Analysis in Clinical Practice: Focus on Lung Cancer
by: Pasquale Pisapia, et al.
Published: (2021-07-01) -
Targeting KRAS in NSCLC: Old Failures and New Options for “Non-G12c” Patients
by: Francesca Jacobs, et al.
Published: (2021-12-01) -
Next Generation Sequencing in Cytopathology: Focus on Non-Small Cell Lung Cancer
by: Pasquale Pisapia, et al.
Published: (2021-02-01)